Financials
Value Q2, 25Q3, 25 TTM Selling/general/admin expenses 6.38 M5.54 M — Research & development —— — Operating income 46.7 M46.27 M — Non-Operating Income, Total 28 M37.78 M — Interest expense, net of interest capitalized 37.02 M38.82 M — Non-Operating Income, excl. Interest Expenses -9.02 M-1.03 M — Unusual income/expense —— — Pretax income 37.94 M46.57 M — Equity in earnings —— — Taxes —— — Non-controlling/minority interest —— — After tax other income/expense —— — Net income before discontinued operations 18.7 M8.49 M — Discontinued operations —— — Net income 18.7 M8.49 M — Dilution adjustment —— — Preferred dividends —— — Diluted net income available to common stockholders 18.7 M8.49 M — Basic earnings per share (Basic EPS) —— — Diluted earnings per share (Diluted EPS) —— — Average basic shares outstanding —— — Diluted shares outstanding —— — EBITDA 143.55 M153.29 M — EBIT 100.71 M101.26 M — Cost of revenue 35.17 M42.92 M — Other cost of goods sold —— — Depreciation & amortization (cash flow) 42.84 M52.03 M —